Alemtuzumab and CHOP in T-cell Lymphoma

Clinical trial NCT00646854 · COMPLETED

Trial details

NCT number: NCT00646854
Sponsor: Aarhus University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2008-06-01
Primary completion: 2016-12-31
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.